Canaan Partners X LLC Iterum Therapeutics PLC Transaction History
Canaan Partners X LLC
- $74.7 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding ITRM
# of Institutions
1Shares Held
66Call Options Held
0Put Options Held
0About Iterum Therapeutics plc
- Ticker ITRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,233,400
- Market Cap $13.2M
- Description
- Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...